Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neurodegenerative Diseases

• Publication date

  2010-03-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000295663PMID 20224285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

  2008cited by this paper
• High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

  2008cited by this paper
• Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults

  2008cited by this paper
• Circulating Blood Markers and Functional Impairment in Peripheral Arterial Disease

  2008cited by this paper
• Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated

  2008cited by this paper
• Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort.

  2008cited by this paper
• The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

  2008cited by this paper
• The central role of glutathione in the pathophysiology of human diseases

  2007cited by this paper
• Bioenergetic and Antioxidant Properties of Coenzyme Q10: Recent Developments

  2007cited by this paper
• Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.

  2007cited by this paper
• Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease.

  2007cited by this paper
• The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system.

  2007cited by this paper
• Oxidative stress and aberrant signaling in aging and cognitive decline

  2007cited by this paper
• Donepezil: an update

  2007cited by this paper
• Vascular oxidative stress in Alzheimer disease.

  2007cited by this paper
• Nitric Oxide and Nitroxidative Stress in Alzheimer's Disease

  2007cited by this paper
• Homocysteine and electroencephalographic rhythms in Alzheimer disease: a multicentric study.

  2007cited by this paper
• F2-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease

  2007cited by this paper
• Ginkgo biloba extract EGb® 761 increases endothelial nitric oxide production in vitro and in vivo

  2007cited by this paper
• Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

  2007cited by this paper
• Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features

  2007cited by this paper
• F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.

  2007cited by this paper
• Selenium in chemistry and biochemistry in comparison to sulfur

  2007cited by this paper
• Could Carnosine or Related Structures Suppress Alzheimer's Disease?

  2007cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Donepezil improves cognitive function and reduces decline in activities of daily living in people with severe Alzheimer’s disease

  2006cited by this paper
• In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease.

  2006cited by this paper
• Heparan sulfate proteoglycans and the emergence of neuronal connectivity.

  2006cited by this paper
• Evidence that Perutz's double-beta-stranded subunit structure for beta-amyloids also applies to their channel-forming structures in membranes.

  2006cited by this paper
• Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study

  2006cited by this paper
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.

  2006cited by this paper
• Evidence that Perutz's double-β-stranded subunit structure for β-amyloids also applies to their channel-forming structures in membranes

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

  2005cited by this paper
• F2-Isoprostanes in Alzheimer and Other Neurodegenerative Diseases

  2005cited by this paper
• Carnosine and carnosine-related antioxidants: a review.

  2005cited by this paper
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Mitochondrial metabolism of reactive oxygen species

  2005cited by this paper
• Impairment of glutathione biosynthetic pathway in uraemia and dialysis.

  2005cited by this paper
• Role of nitric oxide, nitroxidative and oxidative stress in wound healing.

  2005cited by this paper
• Homocysteine and folate as risk factors for dementia and Alzheimer disease.

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

  2005cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• Impact of antioxidants, zinc, and copper on cognition in the elderly

  2004cited by this paper
• Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.

  2004cited by this paper
• Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells

  2004cited by this paper
• Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease

  2004cited by this paper
• Glutathione metabolism and its implications for health.

  2004cited by this paper
• Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.

  2004cited by this paper
• Glycosaminoglycans as Potential Future Treatment of Alzheimer’s Disease

  2004cited by this paper
• DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations

  2004cited by this paper
• Folic acid with or without vitamin B12 for cognition and dementia.

  2003cited by this paper
• DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations

  2003cited by this paper
• Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

  2002cited by this paper
• Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

  2002cited by this paper
• Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

  2002cited by this paper
• Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

  2002cited by this paper
• Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Homocysteine metabolism in children with Down syndrome: in vitro modulation.

  2001cited by this paper
• Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease

  2001cited by this paper
• Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

  2001cited by this paper
• Neuronal and Glial Coexpression of Argininosuccinate Synthetase and Inducible Nitric Oxide Synthase in Alzheimer Disease

  2001cited by this paper
• Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress.

  2001cited by this paper
• Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.

  2001cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• A beta vasoactivity in vivo.

  2000cited by this paper
• Oxidative stress and Alzheimer disease.

  2000cited by this paper
• Aβ Vasoactivity in Vivo

  2000cited by this paper
• A simple test to monitor oxidative stress.

  1999cited by this paper
• Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.

  1999cited by this paper
• Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.

  1998cited by this paper
• Cerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon?

  1997cited by this paper
• Alzheimer amyloid β‐peptides exhibit ionophore‐like properties in human erythrocytes

  1995cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994influential reference
• Vascular dementia

  1993cited by this paper
• A morphometric study of the blood-brain barrier in Alzheimer's disease.

  1992cited by this paper
• The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.

  1991cited by this paper
• Oxidative degradation of rat mast-cell heparin proteoglycan.

  1990cited by this paper
• Degradation of human proteoglycan aggregate induced by hydrogen peroxide. Protein fragmentation, amino acid modification and hyaluronic acid cleavage.

  1989cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• The impact of recent approvals on future alzheimer’s disease clinical development: Statistical considerations for combination trials

  2025cites this paper
• Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial

  2025cites this paper
• Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial

  2025cites this paper
• Management of Alzheimer's Disease Through Nutrition

  2025cites this paper
• First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease

  2024cites this paper
• Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis

  2024cites this paper
• Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis.

  2023cites this paper
• Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment

  2023cites this paper
• Dysmenorrhea Clinical Pharmacology: Dose Finding of Physiological Modulators in Foods or Capsules

  2022cites this paper
• Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper

  2022cites this paper
• Detection of Balenine in Mouse Plasma after Administration of Opah-Derived Balenine by HPLC with PITC Pre-Column Derivatization

  2022cites this paper
• Mechanistic Link between Vitamin B12 and Alzheimer’s Disease

  2022cites this paper
• Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic

  2022influential citation
• A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients

  2022cites this paper
• Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation

  2022cites this paper
• A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease

  2022cites this paper
• Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation

  2021cites this paper
• The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis

  2021cites this paper
• Alzheimer’s Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review

  2021influential citation
• Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

  2021cites this paper
• Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.

  2021cites this paper
• Neuromodulation of BAG co-chaperones by HIV-1 viral proteins and H2O2: implications for HIV-associated neurological disorders

  2021cites this paper
• Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review

  2021influential citation
• Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling

  2021cites this paper
• Selenium concentrations in elderly people with Alzheimer's disease: a cross-sectional study with control group.

  2021cites this paper
• Hydrogen Sulfide and Carnosine: Modulation of Oxidative Stress and Inflammation in Kidney and Brain Axis

  2020cites this paper
• Influence of Histidine Administration on Ammonia and Amino Acid Metabolism: A Review.

  2020cites this paper
• The Traditional Formula Kai-Xin-San Alleviates Polyglutamine-Mediated Neurotoxicity by Modulating Proteostasis Network in Caenorhabditis elegans

  2020cites this paper
• Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement

  2020cites this paper
• Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia

  2020cites this paper
• Diet Associated with Inflammation and Alzheimer’s Disease

  2019cites this paper
• The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence

  2019cites this paper
• Une consommation accrue de carbohydrates fermentescibles entraîne des symptômes de type SII : vers une meilleure compréhension des mécanismes impliqués

  2019cites this paper
• Popular Herbal and Natural Remedies Used in Psychiatry.

  2018cites this paper
• Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease

  2018cites this paper
• Protective Effects of Indian Spice Curcumin Against Amyloid Beta in Alzheimer’s Disease

  2018cites this paper
• Effects of topography and soil properties on soil selenium distribution and bioavailability (phosphate extraction): A case study in Yongjia County, China.

  2018cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2017cites this paper
• Reactive Carbonyl Species Scavengers—Novel Therapeutic Approaches for Chronic Diseases

  2017cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2017cites this paper
• Multi-nutrient interventions and brain metabolism in Alzheimer's disease: a spectrum of effects

  2017cites this paper
• Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.

  2017cites this paper
• p-Chloro-diphenyl diselenide reverses memory impairment-related to stress caused by corticosterone and modulates hippocampal [(3)H]glutamate uptake in mice.

  2016cites this paper
• Alzheimer,s Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome

  2016cites this paper
• Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.

  2016cites this paper
• The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.

  2015cites this paper
• Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease

  2015cites this paper
• Carnosine and Related Peptides: Therapeutic Potential in Age-Related Disorders.

  2015cites this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cites this paper
• Antioxidants as a preventive therapeutic option for age related neurodegenerative diseases

  2015cites this paper
• Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.

  2015cites this paper
• Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.

  2015cites this paper
• Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress.

  2015cites this paper
• REDOX PROCESSES AND OXIDATIVE STRESS IN CELL AND TISSUE DAMAGE

  2015cites this paper
• Nutritional approaches to mitigating cognitive decline and maintaining function in Alzheimer's disease: Transgenic mouse models, combinatorial approaches and dietary supplementation with folate and S-adenosyl methionine

  2015cites this paper
• Antioxidant Plant Polyphenols and Cognitive Disorders

  2015cites this paper
• Activity of a Combination of Physiological Modulators in Limiting Side Effects in Patients Suffering from Primary Hypothyroidism during Levothyroxine Treatment

  2015cites this paper
• Treatment with carnosine reduces hypoxia-ischemia brain damage in a neonatal rat model.

  2014cites this paper
• Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.

  2014cites this paper
• Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.

  2014cites this paper
• Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.

  2014cites this paper
• Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease.

  2014cites this paper
• Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials.

  2014cites this paper
• Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on Aβ1-42 Fibril Formation

  2013cites this paper
• Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats.

  2013cites this paper
• Multifunctional iron-chelators with protective roles against neurodegenerative diseases.

  2013cites this paper
• Nutrition and the Risk of Alzheimer's Disease

  2013cites this paper
• β-Alanyl-L-Histidine Rescues Cognitive Deficits Caused by Feeding a High Fat Diet in a Transgenic Mouse Model of Alzheimer's Disease

  2013cites this paper
• Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.

  2013cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs

  2012cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2012cites this paper
• Positive argument for debate in J Neural Transmission: Alzheimer’s disease: are we intervening too late? Yes, by years if not decades

  2012cites this paper
• Evaluation of oxidative stress after treatment with low estrogen contraceptive either alone or associated with specific antioxidant therapy.

  2012cites this paper
• Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

  2012cites this paper
• Nutrition and Dementia: Are we Asking the Right Questions?

  2012cites this paper
• Redox State in Professional Cyclists Following Competitive Sports Activity

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Utility of imaging for nutritional intervention studies in Alzheimer's disease.

  2011cites this paper
• Selenium and Alzheimer's Disease: A Systematic Review

  2011cites this paper
• Memory Function in a Mouse Genetic Model of Alzheimer's Disease

  2011cites this paper
• Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors

  2011cites this paper
• Understanding the Broad-Spectrum Neuroprotective Action Profile of Green Tea Polyphenols in Aging and Neurodegenerative Diseases

  2011cites this paper
• Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action.

  2011cites this paper
• Selenium and clinical trials: new therapeutic evidence for multiple diseases.

  2011cites this paper
• Cognitive Enhancers in Moderate to Severe Alzheimer's Disease:

  2011cites this paper
• Anti-ageing potential of carnosine: approaches toward successful ageing

  2010cites this paper